Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Pusceddu · SciRah

Researcher profile · Semantic Scholar

S. Pusceddu

Share profile

S. Pusceddu — researcher profile on SciRah

h-index: 31
Works: 199
Citations: 3,376

Most-cited papers

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer
F. Nichetti, S. Rota, P. Ambrosini, C. Pircher +12 more
2024JAMA Network Open126 citations Open access
Semantic Scholar
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
A. Facciorusso, Mohamed A. Abd El Aziz, N. Tartaglia, D. Ramai +6 more
2020Cancers95 citations Open access
Semantic Scholar
Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
A. Facciorusso, Mohamed A. Abd El Aziz, Siddharth Singh, S. Pusceddu +3 more
2020Cancers89 citations Open access
Semantic Scholar
Spartalizumab in metastatic, well/poorly-differentiated neuroendocrine neoplasms.
James C. Yao, J. Strosberg, N. Fazio, M. Pavel +17 more
2021Endocrine-Related Cancer76 citations Open access
Semantic Scholar
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study.
N. Brighi, S. La Rosa, G. Rossi, F. Grillo +20 more
2020Annals of Surgery68 citations
Semantic Scholar
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis.
F. Petrelli, A. Ghidini, M. Torchio, N. Prinzi +14 more
2019Radiotherapy and Oncology65 citations
Semantic Scholar
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
S. Pusceddu, N. Prinzi, S. Tafuto, T. Ibrahim +53 more
2022JAMA Network Open58 citations Open access
Semantic Scholar
Management of the congenital solitary kidney: consensus recommendations of the Italian Society of Pediatric Nephrology
C. La Scola, A. Ammenti, Cristina Bertulli, M. Bodria +21 more
2022Pediatric nephrology (Berlin, West)49 citations Open access
Semantic Scholar
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro‐entero‐pancreatic neuroendocrine neoplasms
M. Milione, R. Miceli, F. Barretta, A. Pellegrinelli +15 more
2019The Journal of Pathology: Clinical Research41 citations Open access
Semantic Scholar
Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
G. Centonze, P. Maisonneuve, M. Simbolo, V. Lagano +20 more
2022Histopathology40 citations Open access
Semantic Scholar
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study.
N. Brighi, F. Panzuto, R. Modica, F. Gelsomino +13 more
2019The Oncologist36 citations Open access
Semantic Scholar
Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study.
A. Veltroni, Elisa Cosaro, F. Spada, N. Fazio +16 more
2020European Journal of Endocrinology31 citations Open access
Semantic Scholar
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis
M. Milione, P. Maisonneuve, F. Grillo, A. Mangogna +23 more
2020Neuroendocrinology30 citations Open access
Semantic Scholar
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)
C. Vernieri, S. Pusceddu, G. Fucà, P. Indelicato +11 more
2019International Journal of Cancer26 citations Open access
Semantic Scholar
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE
M. Maccauro, Mariarosaria Cuomo, M. Bauckneht, Matteo Bagnalasta +11 more
2024European Journal of Nuclear Medicine and Molecular Imaging23 citations
Semantic Scholar
Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
N. Prinzi, R. Rossi, C. Proto, G. Leuzzi +14 more
2020Clinical Lung Cancer23 citations
Semantic Scholar
Differential Diagnosis and Management of Diarrhea in Patients with Neuroendocrine Tumors
S. Pusceddu, R. Rossi, M. Torchio, N. Prinzi +14 more
2020Journal of Clinical Medicine22 citations Open access
Semantic Scholar
One size does not fit all for pancreatic cancers: A review on rare histologies and therapeutic approaches
M. Niger, M. Prisciandaro, M. Antista, M. Monica +12 more
2020World Journal of Gastrointestinal Oncology22 citations Open access
Semantic Scholar
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan
F. Pietrantonio, F. Morano, M. Niger, S. Corallo +21 more
2020Clinical colorectal cancer21 citations Open access
Semantic Scholar
Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined Groups
G. Centonze, D. Biganzoli, N. Prinzi, S. Pusceddu +10 more
2020Cancers21 citations Open access
Semantic Scholar
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET Study
S. Pusceddu, C. Vernieri, M. di Maio, N. Prinzi +10 more
2021Cancers20 citations Open access
Semantic Scholar
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
F. Panzuto, M. Maccauro, D. Campana, A. Faggiano +23 more
2020Journal of Endocrinological Investigation19 citations Open access
Semantic Scholar
Ascl1 and OTP tumour expressions are associated with disease‐free survival in lung atypical carcinoids
G. Centonze, P. Maisonneuve, M. Simbolo, V. Lagano +17 more
2023Histopathology17 citations Open access
Semantic Scholar
Assessment of the Risk of Nodal Involvement in Rectal Neuroendocrine Neoplasms: The NOVARA Score, a Multicentre Retrospective Study
A. Ricci, S. Pusceddu, F. Panzuto, F. Gelsomino +10 more
2022Journal of Clinical Medicine17 citations Open access
Semantic Scholar
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis
G. Centonze, P. Maisonneuve, N. Prinzi, S. Pusceddu +37 more
2022Neuroendocrinology17 citations Open access
Semantic Scholar
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas.
C. Liverani, Alberto Bongiovanni, F. Foca, F. Bergamo +25 more
2024European Journal of Cancer16 citations Open access
Semantic Scholar
Assessing the safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic and thoracic neuroendocrine tumors: rationale and protocol of the phase II LOLA trial
F. Corti, M. P. Brizzi, V. Amoroso, D. Giuffrida +17 more
2023BMC Cancer16 citations Open access
Semantic Scholar
Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective
M. Prisciandaro, M. Antista, A. Raimondi, F. Corti +15 more
2022Frontiers in Oncology16 citations Open access
Semantic Scholar
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study.
S. Massironi, D. Campana, S. Pusceddu, M. Albertelli +20 more
2020Digestive and Liver Disease16 citations
Semantic Scholar
Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms
Valentina Angerilli, G. Sabella, M. Simbolo, V. Lagano +13 more
2024British Journal of Cancer15 citations Open access
Semantic Scholar
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol
Alberto Bongiovanni, C. Liverani, S. Pusceddu, S. Leo +12 more
2020BMJ Open15 citations Open access
Semantic Scholar
Epidemiology of gastroenteropancreatic neuroendocrine neoplasms: a review and protocol presentation for bridging tumor registry data with the Italian association for neuroendocrine tumors (Itanet) national database
F. Panzuto, S. Partelli, D. Campana, F. D. de Braud +44 more
2024Endocrine14 citations Open access
Semantic Scholar
How to recognize and manage psychosomatic pain in the pediatric emergency department
G. Cozzi, A. Lucarelli, F. Borrometi, I. Corsini +5 more
2021Italian Journal of Pediatrics13 citations Open access
Semantic Scholar
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidence
S. Pusceddu, C. Vernieri, N. Prinzi, M. Torchio +11 more
2020Therapeutic Advances in Gastroenterology13 citations Open access
Semantic Scholar
Digestive MiNENs: Could histological classification and molecular characterization drive clinical outcome and therapeutic approach?
L. Cattaneo, G. Centonze, G. Sabella, V. Lagano +9 more
2023Critical reviews in oncology/hematology11 citations
Semantic Scholar
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
C. Vernieri, S. Pusceddu, F. De Braud
2019Frontiers in Oncology11 citations Open access
Semantic Scholar
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma.
M. Laganà, M. Habra, H. Remde, M. Almeida +18 more
2024European Journal of Cancer10 citations Open access
Semantic Scholar
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study
R. Ruggeri, B. Altieri, P. Razzore, F. Retta +37 more
2023Journal of Endocrinological Investigation10 citations Open access
Semantic Scholar
Prognostic features of gastro‐entero‐pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties
K. Kankava, P. Maisonneuve, A. Mangogna, G. Centonze +11 more
2021Journal of neuroendocrinology10 citations Open access
Semantic Scholar
Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
G. Centonze, V. Lagano, G. Sabella, A. Mangogna +15 more
2021Journal of Clinical Medicine10 citations Open access
Semantic Scholar
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2
S. Pusceddu, F. Corti, N. Prinzi, F. Nichetti +24 more
2023Journal of Hematology & Oncology9 citations Open access
Semantic Scholar
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
M. Niger, F. Nichetti, A. Casadei-Gardini, F. Morano +29 more
2022Molecular Oncology9 citations Open access
Semantic Scholar
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
G. Lamberti, N. Prinzi, Alberto Bongiovanni, M. Torniai +8 more
2023Diagnostics8 citations Open access
Semantic Scholar
Multidisciplinary Approach to the Diagnosis of Occult Primary Neuroendocrine Neoplasm: A Clinical Challenge
R. Rossi, F. Corti, S. Pusceddu, M. Milione +6 more
2023Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Entering the third decade of experience with octreotide LAR in neuroendocrine tumors: A review of current knowledge
S. Pusceddu, N. Prinzi, A. Raimondi, F. Corti +8 more
2019Tumori8 citations
Semantic Scholar
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial.
V. Nasca, N. Prinzi, J. Coppa, M. Prisciandaro +19 more
2024European Journal of Cancer7 citations
Semantic Scholar
Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives
M. Simbolo, G. Centonze, A. Gkountakos, Valentina Monti +25 more
2024Virchows Archiv7 citations Open access
Semantic Scholar
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort
F. Panzuto, Elisa Andrini, G. Lamberti, S. Pusceddu +12 more
2024Journal of Clinical Medicine7 citations Open access
Semantic Scholar
Unveiling the Prognostic Role of Synaptophysin in Conventional Colorectal Carcinomas
G. Sabella, G. Centonze, V. Lagano, A. Scardino +17 more
2025Neuroendocrinology6 citations Open access
Semantic Scholar
Metastatic pheochromocytomas and paragangliomas: where are we?
N. Prinzi, F. Corti, M. Torchio, M. Niger +12 more
2022Tumori6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Prinzi×28
Invite
N. Prinzi — researcher profile on SciRah
M. Milione×25
Invite
M. Milione — researcher profile on SciRah
F. De Braud×17
Invite
F. De Braud — researcher profile on SciRah
F. Corti×15
Invite
F. Corti — researcher profile on SciRah

×14

Invite

J. Coppa — researcher profile on SciRah

G. Centonze×14

Invite

G. Centonze — researcher profile on SciRah

M. Di Bartolomeo×13

Invite

M. Di Bartolomeo — researcher profile on SciRah

A. Mangogna×12

Invite

A. Mangogna — researcher profile on SciRah

Invite

G. Sabella — researcher profile on SciRah

V. Mazzaferro×10

Invite

V. Mazzaferro — researcher profile on SciRah

Invite

M. Niger — researcher profile on SciRah

Invite

M. Torchio — researcher profile on SciRah